Platelet Endothelial Cell Adhesion Molecule (PECAM/CD31) Blockade Modulates Neutrophil Recruitment Patterns and

Neil A Nadkarni1, Erika Arias2, Raymond Fang3

  • 1Department of Neurology, Northwestern University, Chicago, Illinois.

Insights

Blocking platelet endothelial cell adhesion molecule-1 (PECAM) in stroke models altered polymorphonuclear leukocyte (PMN) distribution, reducing infarct size. This suggests targeting PMN infiltration patterns may offer therapeutic benefits for ischemic stroke.

Area of Science:

  • Neuroscience
  • Immunology
  • Cardiovascular Research

Background:

  • Polymorphonuclear leukocytes (PMNs) contribute to inflammatory damage in ischemic stroke.
  • Previous attempts to block PMN transendothelial migration (TEM) have yielded limited clinical success.
  • Understanding PMN infiltration patterns is crucial for developing effective stroke therapies.

Purpose of the Study:

  • To quantify leukocyte infiltration patterns in ischemia-reperfusion injury (I/RI).
  • To investigate the effect of blocking platelet endothelial cell adhesion molecule-1 (PECAM) on PMN distribution and infarct volume.
  • To explore the therapeutic potential of modulating PMN infiltration in stroke.

Main Methods:

  • Utilized LysM-eGFP mice and microscopy to visualize myeloid leukocyte recruitment after I/RI.
  • Employed a semiautomated process to map PMN positions in brain sections.
  • Administered PECAM function-blocking antibodies to modulate leukocyte infiltration.

Main Results:

  • Leukocyte distribution was heterogeneous across the infarct at 24 and 72 hours post-I/RI.
  • PECAM blockade altered PMN distribution, increasing cortical infiltration (24h: 89% vs. 72%; 72h: 69% vs. 51%).
  • PECAM blockade correlated with a significant decrease in infarct volume.

Conclusions:

  • Cerebrovascular TEM in I/RI predominantly occurs at the cortical surface.
  • Modulating PMN infiltration patterns, specifically cortical distribution, may reduce stroke-induced damage.
  • Targeting PECAM offers a potential therapeutic strategy for ischemic stroke by mitigating PMN-exacerbated injury.

Related Concept Videos